Clinical Effect of TKI Dose-Escalation after Disease Progression in Patients with Metastatic Renal Cell Carcinoma

Clinical Effect of TKI Dose-Escalation after Disease Progression in Patients with Metastatic Renal Cell Carcinoma

kidneycancer

4 years
614 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Moshe C. Ornstein MD MA of the Cleveland Clinic Taussig Cancer Institute presents "Clinical Effect of TKI Dose-Escalation after Disease Progression in Patients with Metastatic Renal Cell Carcinoma" at the 14th International Kidney Cancer Symposium.
Up Next Autoplay